Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases
10.12997/jla.2021.10.2.123
- Author:
Fernando F. ANHÊ
1
;
Benjamin A. H. JENSEN
;
Lais Rossi PERAZZA
;
André TCHERNOF
;
Jonathan D. SCHERTZER
;
André MARETTE
Author Information
1. Department of Biochemistry and Biomedical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
- Publication Type:Opinion
- From:Journal of Lipid and Atherosclerosis
2021;10(2):129-129
- CountryRepublic of Korea
- Language:English
-
Abstract:
Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.
